Replay Webinar – Demencia and AI

On November 9, 2022, our neuroradiologist and CEO, Arnaud Attyé, hosted a webinar for radiologists in partnership with Bayer.

In current practice, MRI brain scans are analysed visually, using automatic segmentation software. Such software is potentially useful for detecting quantitative abnormalities and their evolution over time.

However, they also have their limitations. These relate in particular to the lack of information on the diseases from which patients suffer. But they are also linked to the so-called “machine effect”. This is induced by the different magnetic fields applied, which can give information that reflects the type of machine more than the type of disease. This is why GeodAIsics creates digital twins adapted to each new patient.

Imaging doesn’t explain everything, and it’s important for artificial intelligence to colour in the “grey areas” where the patient is carrying a disease that the system doesn’t know about.

This is exactly the aim of the clinical decision support systems we are developing.

On the program:

• An overview of visual analysis as it is performed in practice.
• What are the limitations of segmentation software?
• The solutions we offer thanks to AI through population analysis and digital twins.
• A concrete explanation of how our DementIA software works, based on case studies.